Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
20 studies found for:    "Galactorrhoea-Hyperprolactinaemia"
Show Display Options
Rank Status Study
1 Recruiting Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia
Conditions: Schizophrenia;   Schizophrenic Disorder;   Hyperprolactinemia;   Hyperprolactinaemia
Interventions: Drug: PGD granules;   Drug: Placebo
2 Unknown  Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
Conditions: Schizophrenia;   Hyperprolactinemia
Intervention: Drug: Bromocriptin
3 Completed Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia
Condition: Risperidone-induced Hyperprolactinemia
Intervention: Drug: Calcium and Vitamin D
4 Recruiting Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
Condition: Hyperprolactinemia
Interventions: Drug: Aripiprazole;   Drug: Placebo
5 Completed Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine
Conditions: APS-related Hyperprolactinaemia;   Schizophrenia;   Bipolar Disorder
6 Recruiting Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment
Conditions: Hyperprolactinemia;   Insulin Resistance
Intervention: Other: Cabergoline
7 Unknown  Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
Conditions: Hyperprolactinemia;   Weight Gain;   Dyslipidemia
Intervention: Drug: Abilify  (aripiprazole)
8 Unknown  Aripiprazole and Prolactin Study
Condition: Hyperprolactinemia
Intervention: Drug: Aripiprazole
9 Recruiting Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON
Conditions: Polycystic Ovary Syndrome;   Endometriosis;   Hyperprolactinemia
Intervention: Other: Fertility treatment
10 Completed
Has Results
The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events
Conditions: Parkinson's Disease;   Hyperprolactinemia
Intervention: Other: Retrospective study-
11 Completed
Has Results
Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)
Conditions: Parkinson's Disease;   Hyperprolactinemia
Intervention: Drug: Study Drug
12 Completed Characterization of Macroprolactinemia
Condition: Hyperprolactinemia
13 Completed Endometriosis Patients Undergoing Quinagolide Treatment
Conditions: Hyperprolactinemia;   Endometriosis
Intervention: Procedure: ENDOMETRIAL BIOPSY
14 Recruiting Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia
Condition: Schizophrenia
Intervention: Drug: Aripiprazole
15 Active, not recruiting Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly.
Conditions: Acromegaly;   Surgery
16 Terminated
Has Results
The Luveris In Vitro Fertilization Trial
Conditions: Infertility;   Hypothalamic Amenorrhea;   Hyperprolactinemia
Interventions: Drug: Luveris fixed dose;   Drug: Luveris increasing dose
17 Recruiting A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders
Conditions: Sexual Dysfunction;   Hyperprolactinemia
Interventions: Drug: Aripiprazole;   Drug: risperidone or paliperidone
18 Completed The Relationship of PRL and Polycystic Ovary Syndrome (PCOS) in Taiwan's Women
Condition: Polycystic Ovary Syndrome
19 Completed Insulin Resistance in Women With Prolactinoma
Conditions: Prolactinoma;   Insulin Resistance;   Hyperlipidemia
20 Terminated
Has Results
Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Amantadine Hydrochloride, USP;   Drug: Placebo

Indicates status has not been verified in more than two years